Three-Year Outcomes of Biodegradable Polymer-Coated Ultra-Thin (60 µm) Sirolimus-Eluting Stents in Real-World Clinical Practice.

CONCLUSION: Treatment of patients with CAD in real-world clinical practice was associated with sustained clinical safety and low rates of restenosis, stent thrombosis and MACE up to 3 years after Supraflex SES implantation. PMID: 31210252 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31210252?dopt=Abstract

Source: Annals of the Academy of Medicine, Singapore - April 30, 2019 Category: General Medicine Authors: Chandwani P, Meel B, Singhal R, Jangid K, Ahmed R, Yadav M, Gupta AK, Chopra R Tags: Ann Acad Med Singapore Source Type: research